Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings Share Price

0.000.00%
us flag iconLast trade - 00:00
TechnologySpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-20.79%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-71.69%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of Thermogenesis Holdings EPS forecast chart

Profile Summary

ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company operates through two segments: Device Segment and Clinical Development Segment. It provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications. It manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System, BioArchive Automated Cryopreservation System and PXP Point-of-Care System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Large Scale Cell Processing and Biomanufacturing includes X-Series Products and CAR-TXpress Platform.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
July 3rd, 1986
Public Since
June 6th, 1994
No. of Shareholders
154
No. of Employees
40
Sector
Office Equipment
Industry
Technology
Exchange
us flag iconNASDAQ Capital Market
Shares in Issue
11,911,784

THMO Share Price Performance

Latest News for THMO

Upcoming Events for THMO

Thermogenesis Holdings Inc Annual Shareholders Meeting

Q4 2021 Thermogenesis Holdings Inc Earnings Release

Q1 2022 Thermogenesis Holdings Inc Earnings Release

Similar to THMO

Picture of LightPath Technologies logo

LightPath Technologies

us flag iconNASDAQ Capital Market

Picture of Voxeljet AG logo

Voxeljet AG

us flag iconNASDAQ Capital Market

FAQ

Or unlock with your email

Or unlock with your email